Workflow
GSK's Specialty Medicines Surge - Still Looks Undervalued In 2025

GSK plc (NYSE: GSK ) is a well-known biopharmaceutical company that develops specialty and general drugs, as well as vaccines. Their Q1 2025 results showed good momentum, particularly in the specialty medicines segment. GSK's oncology performance was excellent, but other specialty areas, includingMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio Univers ...